George Soros Soros Fund Management
George Soros is the founder of Soros Fund Management and one of the most famous macro investors in modern markets. He is best known for large global bets informed by his theory of reflexivity, including the 1992 sterling trade. Though the firm later evolved as a family office, its equity filings and historical track record remain a reference point for students of macro and activist-era hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.5M |
| 2 |
Aramark
ARMK
|
+$46.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$39.3M |
| 4 |
Okta
OKTA
|
+$39.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$241M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$239M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$90.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$82.4M |
| 5 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$65.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Industrials | 7.12% |
| 3 | Financials | 5.45% |
| 4 | Communication Services | 5.11% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$85.9B
| $14.4M | 0.24% |
15,000
-2,500
| -14% | -$2.38M |
|
77
KeyCorp
KEY
$23.3B
| $14.3M | 0.24% |
902,000
+307,000
| +52% | +$4.43M |
|
78
Goldman Sachs
GS
$303B
| $14M | 0.23% |
+33,550
| New | +$13M |
|
79
BioMarin Pharmaceuticals
BMRN
$12.9B
| $13.6M | 0.23% |
+155,900
| New | +$14M |
|
80
PUT
General Motors
GM
$77.2B
| $13.6M | 0.23% |
+300,000
| New | +$11.6M |
|
81
Ametek
AME
$54.9B
| $13.4M | 0.22% |
73,334
+12,829
| +21% | +$2.21M |
|
82
Avantor
AVTR
$9.78B
| $12.8M | 0.21% |
500,000
-300,000
| -38% | -$7.14M |
|
83
CALL
BRC Group Holdings
RILY
$286M
| $12.7M | 0.21% |
+600,000
| New | +$12M |
|
84
Danaher
DHR
$154B
| $12.5M | 0.21% |
+50,000
| New | +$12.2M |
|
85
PUT
Lantheus
LNTH
$6.53B
| $12.4M | 0.21% |
+200,000
| New | +$11.8M |
|
|
86
PUT
BRC Group Holdings
RILY
$286M
| $12.3M | 0.2% |
579,800
-213,800
| -27% | -$4.29M |
|
87
Viper Energy
VNOM
$16.3B
| $12.1M | 0.2% |
+313,850
| New | +$10.6M |
|
88
Aurora
AUR
$12.5B
| $12M | 0.2% |
+4,250,000
| New | +$12.2M |
|
89
BrightSpring Health Services
BTSG
$11.6B
| $12M | 0.2% |
+1,101,554
| New | +$11M |
|
90
Freeport-McMoran
FCX
$110B
| $11.8M | 0.2% |
+251,800
| New | +$10.2M |
|
91
argenx
ARGX
$65B
| $11.8M | 0.2% |
+30,000
| New | +$11.6M |
|
92
Evolus
EOLS
$554M
| $11.8M | 0.2% |
840,100
+290,100
| +53% | +$3.77M |
|
93
Rexford Industrial Realty
REXR
$8.3B
| $11.3M | 0.19% |
+225,000
| New | +$11.9M |
|
94
TD Synnex
SNX
$20B
| $11.3M | 0.19% |
+100,000
| New | +$10.4M |
|
95
Norfolk Southern
NSC
$78.8B
| $11.1M | 0.18% |
43,588
-6,230
| -13% | -$1.54M |
|
96
Howard Hughes
HHH
$3.97B
| $10.5M | 0.18% |
+152,105
| New | +$11.3M |
|
|
SWTX
97
DELISTED
SpringWorks Therapeutics
SWTX
| $10M | 0.17% |
+203,946
| New | +$9.43M |
|
98
CME Group
CME
$98.9B
| $9.87M | 0.16% |
45,860
-43,100
| -48% | -$9.05M |
|
|
HA
99
DELISTED
Hawaiian Holdings, Inc.
HA
| $9M | 0.15% |
675,000
+516,965
| +327% | +$7.19M |
|
|
CPE
100
DELISTED
Callon Petroleum Company
CPE
| $8.94M | 0.15% |
+250,000
| New | +$8.16M |
|
Similar funds
George Soros's Q1 2024 Portfolio in Review
As of Q1 2024, George Soros held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
George Soros withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.
Against the trend, George Soros opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.
- George Soros's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
- George Soros added most to Aramark in Q1 2024, an estimated $46.4M increase.
- George Soros's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
- George Soros fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
- George Soros's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
- George Soros opened 78 new positions and closed 81 in Q1 2024.
- George Soros's portfolio value fell 21% quarter-over-quarter to $6.02B.
Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.